At the same time, there are many experimental studies on iron and AKI in mouse models, such as iron chelator, Deferoxamine, and the ferroptosis inhibitor ferrostatin-1, which can reduce the severity of the AKI model by inhibiting the iron toxicity of hemoglobin and hemopexin in proximal tubular cells [35]. Here, HPX is linked to acute kidney injury.